Biocon Sees US Generic Drug Tariffs as Negotiating Tactic
Biocon executive chairperson Kiran Mazumdar-Shaw said the company sees proposed US tariffs on generic drugs as a negotiating threat rather than a likely policy outcome. She told Mint that steep duties would…
